Loading...
XSHE
300595
Market cap1.98bUSD
Dec 05, Last price  
15.61CNY
1D
1.04%
1Q
-13.04%
IPO
34.11%
Name

Autek China Inc

Chart & Performance

D1W1MN
XSHE:300595 chart
P/E
24.42
P/S
7.71
EPS
0.64
Div Yield, %
1.43%
Shrs. gr., 5y
1.08%
Rev. gr., 5y
22.90%
Revenues
1.81b
+4.40%
68,389,14991,010,663129,880,557176,236,652235,018,663311,629,075458,419,766646,903,716870,663,6021,295,045,8441,525,319,0731,737,168,4631,813,611,324
Net income
572m
-14.16%
30,084,26224,800,00563,771,01288,704,847114,037,965150,858,703216,243,022306,889,255433,320,972554,737,175623,848,090666,599,816572,230,427
CFO
685m
-5.32%
19,181,73053,374,81861,909,06280,232,430108,802,312144,709,478148,522,131275,365,341380,935,352630,094,069651,716,838723,384,236684,906,247
Dividend
May 16, 20240.223 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Autek China Inc. engages in the research, development, production, and sale of eye vision and related supporting products. It offers optometry medical devices, such as orthokeratology lenses for vision correction and myopia control. The company was founded in 2001 and is based in Hefei, China.
IPO date
Jan 17, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT